These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 7271386

  • 1. Influence of dihydroergotoxine and piracetam on creatine kinase activity in contusioned spinal cord.
    Atanacković D, Simonić A, Jamnicky B.
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):266-72. PubMed ID: 7271386
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of piracetam on metabolic stages in the rat brain].
    Bonifacj JF, Ferran C, Laborit H.
    Agressologie; 1982 Oct; 23(4):127-9. PubMed ID: 7180984
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of piracetam and dihydroergotoxine on the release of dopamine from the corpus striatum of the rat].
    Wustmann C, Rudolph E, Fischer HD, Dietze M, Schulze S.
    Acta Biol Med Ger; 1980 Oct; 39(8-9):383-5. PubMed ID: 7282216
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deleterious versus neuroprotective effect of metabolic inhibition after traumatic spinal cord injury.
    Torres S, Salgado-Ceballos H, Guizar-Sahagún G, Torres JL, Orozco-Suarez S, Diaz-Ruiz A, Vázquez ME, Collado C, Ríos C.
    Spinal Cord; 2009 Oct; 47(10):745-50. PubMed ID: 19488053
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Mechanism of the cerebrovascular effect of piracetam].
    Mirzoian RS, Gan'shina TS.
    Biull Eksp Biol Med; 1985 Jan; 99(1):64-6. PubMed ID: 3967075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigations to the influence of piracetam on lipid parameters.
    Sittner WD, Richter V, Rassoul F, Wenzel J.
    Pharmazie; 1985 Nov; 40(11):810-1. PubMed ID: 4095139
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.